Spread | 0.16 | ||||
Long position overnight fee Long position overnight fee
Trade size with leverage ~ $5,000.00 Short position overnight fee ~ $4,000.00 | -0.026179% | ||||
Short position overnight fee Short position overnight fee
Trade size with leverage ~ $5,000.00 Short position overnight fee ~ $4,000.00 | 0.003957% | ||||
Overnight fee time | 21:00 (UTC) | ||||
Currency | USD | ||||
Min traded quantity | 1 | ||||
Margin | 20 | ||||
Stock exchange | United States of America | ||||
Commission on trade1 | 0% |
1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information
Prev. Close | 3.31 |
Open | 3.36 |
1-Year Change | 784.21% |
Day's Range | 3.36 - 3.57 |
T2 Biosystems, Inc. (TTOO) is an in vitro diagnostics company. It was founded in 2006 and is headquartered in Massachusetts, US.
The company’s product portfolio includes T2Dx Instrument, T2Candida Panel and T2Bacteria Panel, which are powered by its proprietary T2 Magnetic Resonance (T2MR) technology. These technologies enable US Food and Drug Administration (FDA)-cleared blood tests that identify sepsis-causing pathogens without having to wait for blood culture.
Other test or diagnostics services the company offers include T2Resistance to identify carbapenem resistance genes, T2SARS-CoV-2 panel to detect SARS-CoV-2 virus and T2Biothreat to uncover biothreat pathogens.
The company’s product pipeline covers technologies and products for detecting additional species and antibiotic resistance markers of sepsis pathogens and tests for Lyme disease.
T2Cauris provides detection of the superbug Candida Auris in patient's skin and blood and hospital environmental samples. T2Lyme can identify the bacteria that cause Lyme disease through a direct-from-blood test panel designed to run on the T2Dx Instrument.
T2 Biosystems, Inc. stock started trading on the NASDAQ stock exchange in 2014 under the ticker symbol TTOO. You can track live TTOO share value and price history at Capital.com.